Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Role of radiation therapy for retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative.
Chouliaras K, Senehi R, Ethun CG, Poultsides G, Grignol V, Clarke CN, Roggin KK, Fields RC, Schwartz PB, Ronnekleiv-Kelly SM, D'Agostino R Jr, Johnson EN, Levine EA, Cardona K, Votanopoulos KI. Chouliaras K, et al. Among authors: schwartz pb. J Surg Oncol. 2019 Dec;120(7):1227-1234. doi: 10.1002/jso.25694. Epub 2019 Sep 4. J Surg Oncol. 2019. PMID: 31486096 Free PMC article.
Predictors of Disease-Free and Overall Survival in Retroperitoneal Sarcomas: A Modern 16-Year Multi-Institutional Study from the United States Sarcoma Collaboration (USSC).
Schwartz PB, Vande Walle K, Winslow ER, Ethun CG, Tran TB, Poultsides G, Tseng J, Roggin K, Grignol V, Howard JH, Krasnick BA, Fields RC, Mogal H, Clarke CN, Senehi R, Votanopoulos K, Cardona K, Abbott DE. Schwartz PB, et al. Sarcoma. 2019 Jun 2;2019:5395131. doi: 10.1155/2019/5395131. eCollection 2019. Sarcoma. 2019. PMID: 31281208 Free PMC article.
Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer.
Macedo FI, Ryon E, Maithel SK, Lee RM, Kooby DA, Fields RC, Hawkins WG, Williams G, Maduekwe U, Kim HJ, Ahmad SA, Patel SH, Abbott DE, Schwartz P, Weber SM, Scoggins CR, Martin RCG, Dudeja V, Franceschi D, Livingstone AS, Merchant NB. Macedo FI, et al. Ann Surg. 2019 Sep;270(3):400-413. doi: 10.1097/SLA.0000000000003468. Ann Surg. 2019. PMID: 31283563 Free PMC article.
What Drives High Costs of Cytoreductive Surgery and HIPEC: Patient, Provider or Tumor?
Schwartz PB, Stahl CC, Vande Walle KA, Pokrzywa CJ, Cherney Stafford LM, Aiken T, Barrett J, Acher AW, Leverson G, Ronnekleiv-Kelly S, Weber SM, Abbott DE. Schwartz PB, et al. Ann Surg Oncol. 2020 Dec;27(13):4920-4928. doi: 10.1245/s10434-020-08583-7. Epub 2020 May 15. Ann Surg Oncol. 2020. PMID: 32415351 Free PMC article.
Early vs Late Readmissions in Pancreaticoduodenectomy Patients: Recognizing Comprehensive Episodic Cost to Help Guide Bundled Payment Plans and Hospital Resource Allocation.
Acher AW, Barrett JR, Schwartz PB, Stahl C, Aiken T, Ronnekleiv-Kelly S, Minter RM, Leverson G, Weber S, Abbott DE. Acher AW, et al. Among authors: schwartz pb. J Gastrointest Surg. 2021 Jan;25(1):178-185. doi: 10.1007/s11605-020-04714-3. Epub 2020 Jul 15. J Gastrointest Surg. 2021. PMID: 32671797 Free PMC article.
41 results